Atea Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Atea Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Aviragen Therapeutics (AVIR) Tops Q1 EPS by 1c

May 12, 2025 4:54 PM EDT

Aviragen Therapeutics (NASDAQ: AVIR) reported Q1 EPS of ($0.40), $0.01 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

... More